▶ 調査レポート

アトバコン及びプログアニルの世界市場レポート2020

• 英文タイトル:Global Atovaquone and Proguanil Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。アトバコン及びプログアニルの世界市場レポート2020 / Global Atovaquone and Proguanil Sales Market Report 2020 / 20QY06-00654資料のイメージです。• レポートコード:20QY06-00654
• 出版社/出版日:QYResearch / 2020年6月3日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥600,000 (USD4,000)▷ お問い合わせ
  Multi User¥900,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,200,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、アトバコン及びプログアニルのグローバル市場について種類別(250 mg/100 mg、62.5mg/25mg)、用途別(成人、小児科)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・アトバコン及びプログアニル市場の概要
・世界の主要地域別アトバコン及びプログアニル市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のアトバコン及びプログアニル市場規模2015-2026:種類別(250 mg/100 mg、62.5mg/25mg)
・世界のアトバコン及びプログアニル市場規模2015-2026:用途別(成人、小児科)
・アトバコン及びプログアニルの北米市場規模2015-2020
・アトバコン及びプログアニルのヨーロッパ市場規模2015-2020
・アトバコン及びプログアニルの中国市場規模2015-2020
・アトバコン及びプログアニルの日本市場規模2015-2020
・アトバコン及びプログアニルの東南アジア市場規模2015-2020
・アトバコン及びプログアニルのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(GSK、Glenmark、Mylan Pharmaceuticals、Hetero)
・アトバコン及びプログアニルの製造コスト分析
・販売チャネル、流通業者、顧客
・アトバコン及びプログアニルの市場動向・機会・課題
・調査の結論

Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum.

Market Analysis and Insights: Global Atovaquone and Proguanil Market
The global Atovaquone and Proguanil market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Atovaquone and Proguanil Scope and Market Size
The global Atovaquone and Proguanil market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Atovaquone and Proguanil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Atovaquone and Proguanil market is segmented into
250 mg/100 mg
62.5mg/25mg

Segment by Application, the Atovaquone and Proguanil market is segmented into
Adult
Paediatric
The Atovaquone and Proguanil market is analysed and market size information is provided by regions (countries). Segment by Application, the Atovaquone and Proguanil market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Atovaquone and Proguanil Market Share Analysis
Atovaquone and Proguanil market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Atovaquone and Proguanil business, the date to enter into the Atovaquone and Proguanil market, Atovaquone and Proguanil product introduction, recent developments, etc.
The major vendors covered:
GSK
Glenmark
Mylan Pharmaceuticals
Hetero

レポート目次

Table of Contents

1 Atovaquone and Proguanil Market Overview
1.1 Atovaquone and Proguanil Product Scope
1.2 Atovaquone and Proguanil Segment by Type
1.2.1 Global Atovaquone and Proguanil Sales by Type (2020-2026)
1.2.2 250 mg/100 mg
1.2.3 62.5mg/25mg
1.3 Atovaquone and Proguanil Segment by Application
1.3.1 Global Atovaquone and Proguanil Sales Comparison by Application (2020-2026)
1.3.2 Adult
1.3.3 Paediatric
1.4 Atovaquone and Proguanil Market Estimates and Forecasts (2015-2026)
1.4.1 Global Atovaquone and Proguanil Sales Growth Rate (2015-2026)
1.4.2 Global Atovaquone and Proguanil Revenue and Growth Rate (2015-2026)
1.4.3 Global Atovaquone and Proguanil Price Trends (2015-2026)

2 Atovaquone and Proguanil Estimate and Forecast by Region
2.1 Global Atovaquone and Proguanil Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Atovaquone and Proguanil Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Atovaquone and Proguanil Sales Market Share by Region (2015-2020)
2.2.2 Global Atovaquone and Proguanil Revenue Market Share by Region (2015-2020)
2.3 Global Atovaquone and Proguanil Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Atovaquone and Proguanil Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Atovaquone and Proguanil Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Atovaquone and Proguanil Estimates and Projections (2015-2026)
2.4.2 Europe Atovaquone and Proguanil Estimates and Projections (2015-2026)
2.4.3 China Atovaquone and Proguanil Estimates and Projections (2015-2026)
2.4.4 Japan Atovaquone and Proguanil Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Atovaquone and Proguanil Estimates and Projections (2015-2026)
2.4.6 India Atovaquone and Proguanil Estimates and Projections (2015-2026)
3 Global Atovaquone and Proguanil Competition Landscape by Players
3.1 Global Top Atovaquone and Proguanil Players by Sales (2015-2020)
3.2 Global Top Atovaquone and Proguanil Players by Revenue (2015-2020)
3.3 Global Atovaquone and Proguanil Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atovaquone and Proguanil as of 2019)
3.4 Global Atovaquone and Proguanil Average Price by Company (2015-2020)
3.5 Manufacturers Atovaquone and Proguanil Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Atovaquone and Proguanil Players (Opinion Leaders)
4 Global Atovaquone and Proguanil Market Size by Type
4.1 Global Atovaquone and Proguanil Historic Market Review by Type (2015-2020)
4.1.1 Global Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
4.1.2 Global Atovaquone and Proguanil Revenue Market Share by Type (2015-2020)
4.1.3 Global Atovaquone and Proguanil Price by Type (2014-2020)
4.2 Global Atovaquone and Proguanil Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Atovaquone and Proguanil Sales Forecast by Type (2021-2026)
4.2.2 Global Atovaquone and Proguanil Revenue Forecast by Type (2021-2026)
4.2.3 Global Atovaquone and Proguanil Price Forecast by Type (2021-2026)
5 Global Atovaquone and Proguanil Market Size by Application
5.1 Global Atovaquone and Proguanil Historic Market Review by Application (2015-2020)
5.1.1 Global Atovaquone and Proguanil Sales Market Share by Application (2015-2020)
5.1.2 Global Atovaquone and Proguanil Revenue Market Share by Application (2015-2020)
5.1.3 Global Atovaquone and Proguanil Price by Application (2015-2020)
5.2 Global Atovaquone and Proguanil Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Atovaquone and Proguanil Sales Forecast by Application (2021-2026)
5.2.2 Global Atovaquone and Proguanil Revenue Forecast by Application (2021-2026)
5.2.3 Global Atovaquone and Proguanil Price Forecast by Application (2021-2026)

3 North America Atovaquone and Proguanil Market Facts & Figures
3.2 North America Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
3.3 North America Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
3.4 North America Atovaquone and Proguanil Sales Market Share by Application (2015-2020)

4 Europe Atovaquone and Proguanil Market Facts & Figures
4.2 Europe Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
4.3 Europe Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
4.4 Europe Atovaquone and Proguanil Sales Market Share by Application (2015-2020)

5 China Atovaquone and Proguanil Market Facts & Figures
5.2 China Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
5.3 China Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
5.4 China Atovaquone and Proguanil Sales Market Share by Application (2015-2020)

6 Japan Atovaquone and Proguanil Market Facts & Figures
6.2 Japan Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
6.3 Japan Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
6.4 Japan Atovaquone and Proguanil Sales Market Share by Application (2015-2020)

7 Southeast Asia Atovaquone and Proguanil Market Facts & Figures
7.2 Southeast Asia Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Atovaquone and Proguanil Sales Market Share by Application (2015-2020)

8 India Atovaquone and Proguanil Market Facts & Figures
8.2 India Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
8.3 India Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
8.4 India Atovaquone and Proguanil Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Atovaquone and Proguanil Business
12.1 GSK
12.1.1 GSK Atovaquone and Proguanil Corporation Information
12.1.2 GSK Atovaquone and Proguanil Business Overview and Total Revenue
12.1.3 GSK Atovaquone and Proguanil Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Atovaquone and Proguanil Products Offered
12.1.5 GSK Recent Development
12.2 Glenmark
12.2.1 Glenmark Atovaquone and Proguanil Corporation Information
12.2.2 Glenmark Atovaquone and Proguanil Business Overview and Total Revenue
12.2.3 Glenmark Atovaquone and Proguanil Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Glenmark Atovaquone and Proguanil Products Offered
12.2.5 Glenmark Recent Development
12.3 Mylan Pharmaceuticals
12.3.1 Mylan Pharmaceuticals Atovaquone and Proguanil Corporation Information
12.3.2 Mylan Pharmaceuticals Atovaquone and Proguanil Business Overview and Total Revenue
12.3.3 Mylan Pharmaceuticals Atovaquone and Proguanil Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Pharmaceuticals Atovaquone and Proguanil Products Offered
12.3.5 Mylan Pharmaceuticals Recent Development
12.4 Hetero
12.4.1 Hetero Atovaquone and Proguanil Corporation Information
12.4.2 Hetero Atovaquone and Proguanil Business Overview and Total Revenue
12.4.3 Hetero Atovaquone and Proguanil Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hetero Atovaquone and Proguanil Products Offered
12.4.5 Hetero Recent Development

13 Atovaquone and Proguanil Manufacturing Cost Analysis
13.1 Atovaquone and Proguanil Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Atovaquone and Proguanil
13.4 Atovaquone and Proguanil Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Atovaquone and Proguanil Distributors List
14.3 Atovaquone and Proguanil Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Atovaquone and Proguanil Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Atovaquone and Proguanil Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Atovaquone and Proguanil Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Atovaquone and Proguanil Sales (K MT) by Region (2015-2020)
Table 5. Global Atovaquone and Proguanil Sales Market Share by Region (2015-2020)
Table 6. Global Atovaquone and Proguanil Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Atovaquone and Proguanil Revenue Share by Region (2015-2020)
Table 8. Global Atovaquone and Proguanil Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Atovaquone and Proguanil Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Atovaquone and Proguanil Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Atovaquone and Proguanil Revenue Share Forecast by Region (2021-2026)
Table 12. Global Atovaquone and Proguanil (K MT) of Key Companies (2015-2020)
Table 13. Global Atovaquone and Proguanil Sales Share by Company (2015-2020)
Table 14. Global Atovaquone and Proguanil Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Atovaquone and Proguanil Revenue Share by Company (2015-2020)
Table 16. Global Atovaquone and Proguanil by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atovaquone and Proguanil as of 2019)
Table 17. Global Atovaquone and Proguanil Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Atovaquone and Proguanil Manufacturing Sites and Area Served
Table 19. Manufacturers Atovaquone and Proguanil Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Atovaquone and Proguanil Players
Table 22. Global Atovaquone and Proguanil Sales (K MT) by Type (2015-2020)
Table 23. Global Atovaquone and Proguanil Sales Share by Type (2015-2020)
Table 24. Global Atovaquone and Proguanil Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Atovaquone and Proguanil Price (K MT) by Type (2015-2020)
Table 26. Global Atovaquone and Proguanil Sales Share by Type (2021-2026)
Table 27. Global Atovaquone and Proguanil Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Atovaquone and Proguanil Revenue Share by Type (2021-2026)
Table 29. Global Atovaquone and Proguanil Price (K MT) by Type (2021-2026)
Table 30. Global Atovaquone and Proguanil Sales (K MT) by Application (2015-2020)
Table 31. Global Atovaquone and Proguanil Sales Share by Application (2015-2020)
Table 32. Global Atovaquone and Proguanil Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Atovaquone and Proguanil Price (K MT) by Application (2015-2020)
Table 34. Global Atovaquone and Proguanil Sales (K MT) by Application (2021-2026)
Table 35. Global Atovaquone and Proguanil Sales Share by Application (2021-2026)
Table 36. Global Atovaquone and Proguanil Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Atovaquone and Proguanil Revenue Share by Application (2021-2026)
Table 38. Global Atovaquone and Proguanil Price (K MT) by Application (2021-2026)
Table 39. United States Atovaquone and Proguanil Sales (K MT) by Company (2015-2020)
Table 40. United States Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
Table 41. United States Atovaquone and Proguanil Sales (K MT) by Type (2015-2020)
Table 42. United States Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
Table 43. United States Atovaquone and Proguanil Sales (K MT) by Application (2015-2020)
Table 44. United States Atovaquone and Proguanil Sales Market Share by Application (2015-2020)
Table 45. Europe Atovaquone and Proguanil Sales (K MT) by Company (2015-2020)
Table 46. Europe Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
Table 47. Europe Atovaquone and Proguanil Sales (K MT) by Type (2015-2020)
Table 48. Europe Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
Table 49. Europe Atovaquone and Proguanil Sales (K MT) by Application (2015-2020)
Table 50. Europe Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
Table 51. China Atovaquone and Proguanil Sales (K MT) by Company (2015-2020)
Table 52. China Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
Table 53. China Atovaquone and Proguanil Sales (K MT) by Type (2015-2020)
Table 54. China Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
Table 55. China Atovaquone and Proguanil Sales (K MT) by Application (2015-2020)
Table 56. China Atovaquone and Proguanil Sales Market Share by Application (2015-2020)
Table 57. Japan Atovaquone and Proguanil Sales (K MT) by Company (2015-2020)
Table 58. Japan Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
Table 59. Japan Atovaquone and Proguanil Sales (K MT) by Type (2015-2020)
Table 60. Japan Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
Table 61. Japan Atovaquone and Proguanil Sales (K MT) by Application (2015-2020)
Table 62. Japan Atovaquone and Proguanil Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Atovaquone and Proguanil Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Atovaquone and Proguanil Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Atovaquone and Proguanil Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Atovaquone and Proguanil Sales Market Share by Application (2015-2020)
Table 69. India Atovaquone and Proguanil Sales (K MT) by Company (2015-2020)
Table 70. India Atovaquone and Proguanil Sales Market Share by Company (2015-2020)
Table 71. India Atovaquone and Proguanil Sales (K MT) by Type (2015-2020)
Table 72. India Atovaquone and Proguanil Sales Market Share by Type (2015-2020)
Table 73. India Atovaquone and Proguanil Sales (K MT) by Application (2015-2020)
Table 74. India Atovaquone and Proguanil Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Atovaquone and Proguanil Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. GSK Atovaquone and Proguanil Product
Table 79. GSK Recent Development
Table 80. Glenmark Corporation Information
Table 81. Glenmark Description and Business Overview
Table 82. Glenmark Atovaquone and Proguanil Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Glenmark Atovaquone and Proguanil Product
Table 84. Glenmark Recent Development
Table 85. Mylan Pharmaceuticals Corporation Information
Table 86. Mylan Pharmaceuticals Description and Business Overview
Table 87. Mylan Pharmaceuticals Atovaquone and Proguanil Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Mylan Pharmaceuticals Atovaquone and Proguanil Product
Table 89. Mylan Pharmaceuticals Recent Development
Table 90. Hetero Corporation Information
Table 91. Hetero Description and Business Overview
Table 92. Hetero Atovaquone and Proguanil Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Hetero Atovaquone and Proguanil Product
Table 94. Hetero Recent Development
Table 95. Production Base and Market Concentration Rate of Raw Material
Table 96. Key Suppliers of Raw Materials
Table 97. Atovaquone and Proguanil Distributors List
Table 98. Atovaquone and Proguanil Customers List
Table 99. Market Key Trends
Table 100. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 101. Key Challenges
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Atovaquone and Proguanil Product Picture
Figure 2. Global Atovaquone and Proguanil Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Atovaquone and Proguanil Market Share by Application in 2020 & 2026
Figure 6. Adult Examples
Figure 7. Paediatric Examples
Figure 8. Global Atovaquone and Proguanil Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Atovaquone and Proguanil Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Atovaquone and Proguanil Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Atovaquone and Proguanil Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Atovaquone and Proguanil Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Atovaquone and Proguanil Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Atovaquone and Proguanil Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Atovaquone and Proguanil Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Atovaquone and Proguanil Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Atovaquone and Proguanil Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Atovaquone and Proguanil Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Atovaquone and Proguanil Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Atovaquone and Proguanil Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Atovaquone and Proguanil Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Atovaquone and Proguanil Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Atovaquone and Proguanil Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Atovaquone and Proguanil Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Atovaquone and Proguanil Players Market Share by Revenue in Atovaquone and Proguanil 2015 & 2019
Figure 26. Atovaquone and Proguanil Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Atovaquone and Proguanil Revenue Share by Type (2015-2020)
Figure 28. Global Atovaquone and Proguanil Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Atovaquone and Proguanil Revenue Share by Application (2015-2020)
Figure 30. Global Atovaquone and Proguanil Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Atovaquone and Proguanil Sales Market Share by Type in 2019
Figure 32. United States Atovaquone and Proguanil Sales Market Share by Type in 2019
Figure 33. Europe Atovaquone and Proguanil Sales Market Share by Company in 2019
Figure 34. Europe Atovaquone and Proguanil Sales Market Share by Type in 2019
Figure 35. Europe Atovaquone and Proguanil Sales Market Share by Application in 2019
Figure 36. China Atovaquone and Proguanil Sales Market Share by Company in 2019
Figure 37. China Atovaquone and Proguanil Sales Market Share by Type in 2019
Figure 38. China Atovaquone and Proguanil Sales Market Share by Application in 2019
Figure 39. Japan Atovaquone and Proguanil Sales Market Share by Company in 2019
Figure 40. Japan Atovaquone and Proguanil Sales Market Share by Type in 2019
Figure 41. Japan Atovaquone and Proguanil Sales Market Share by Application in 2019
Figure 42. Southeast Asia Atovaquone and Proguanil Sales Market Share by Company in 2019
Figure 43. Southeast Asia Atovaquone and Proguanil Sales Market Share by Type in 2019
Figure 44. Southeast Asia Atovaquone and Proguanil Sales Market Share by Application in 2019
Figure 45. India Atovaquone and Proguanil Sales Market Share by Company in 2019
Figure 46. India Atovaquone and Proguanil Sales Market Share by Type in 2019
Figure 47. India Atovaquone and Proguanil Sales Market Share by Application in 2019
Figure 48. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Mylan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Hetero Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Atovaquone and Proguanil
Figure 54. Manufacturing Process Analysis of Atovaquone and Proguanil
Figure 55. Atovaquone and Proguanil Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Porter's Five Forces Analysis
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed